Somite
Somite is building foundation models for human stem cells to transform the development of novel cell therapies. Their proprietary technology allows for unprecedented data generation, accelerating discovery and optimization of cell differentiation protocols. Backed by over $47 million in Series A funding led by Khosla Ventures, Somite aims to revolutionize regenerative medicine by enabling faster, cheaper, and more effective cell therapies, opening new therapeutic possibilities.
Industries
Nr. of Employees
small (1-50)
Products
Somite-derived Cell Therapy
A therapy that uses somite-derived cells to replace missing, damaged, or diseased cells for treating various medical conditions.
Somite-derived Cell Therapy
A therapy that uses somite-derived cells to replace missing, damaged, or diseased cells for treating various medical conditions.
Somite-derived Cell Therapy
A therapy that uses somite-derived cells to replace missing, damaged, or diseased cells for treating various medical conditions.
Somite-derived Cell Therapy
A therapy that uses somite-derived cells to replace missing, damaged, or diseased cells for treating various medical conditions.
Digital Twin of the Embryo
A computational model simulating embryo development to guide decision-making in cell therapy protocols.
Digital Twin of the Embryo
A computational model simulating embryo development to guide decision-making in cell therapy and protocol optimization.
Somite-derived Cell Therapy
A therapy that uses somite-derived cells to replace missing, damaged, or diseased cells for treating various medical conditions.
Somite-derived Cell Therapy
A therapy that uses somite-derived cells to replace missing, damaged, or diseased cells for treating various medical conditions.
Somite-derived Cell Therapy
A therapy that uses somite-derived cells to replace missing, damaged, or diseased cells for treating various medical conditions.
Somite-derived Cell Therapy
A therapy that uses somite-derived cells to replace missing, damaged, or diseased cells for treating various medical conditions.
Digital Twin of the Embryo
A computational model simulating embryo development to guide decision-making in cell therapy protocols.
Digital Twin of the Embryo
A computational model simulating embryo development to guide decision-making in cell therapy and protocol optimization.
News & Updates
Somite has raised over $47 million in Series A funding led by Khosla Ventures to develop DeltaStem, a foundation model for producing any cell type for any person. The funding aims to accelerate the development of cell therapies and transform developmental biology into a compute-bound engineering discipline.
Somite has raised over $47 million in Series A funding led by Khosla Ventures to develop DeltaStem, a foundation model for producing any cell type for any person. The funding aims to accelerate the development of cell therapies and transform developmental biology into a compute-bound engineering discipline.